
About Abbott Healthcare Private Limited
Data last updated:
Abbott Healthcare Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Abbott Asia Holdings Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24200MH1997PTC104834. Its GSTIN is 27AAACK3935D1ZS (Maharashtra). The company holds 33 GST registrations, of which 25 are active.
The company has an authorised share capital of ₹64.7 Cr and a paid-up capital of ₹4.04 Cr. It was formerly known as Knoll International Limited and Knoll International Private Limited. It is led by directors including Scott Michael Leinenweber and Ramanathan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. 3 Corporate Park Sion Trombay Road Chembur, Mumbai, Maharashtra, India – 400071.
As per the financials filed for FY 2025, the company reported a revenue of ₹8,811.32 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹1,104.4 Cr (net margin 12.5%) and EBITDA of ₹1,792.39 Cr (EBITDA margin 20.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 9% over five years.
The company has about 8,323 employees on its provident fund (EPFO) records.
The company is associated with 3 brands: Pediasure, Switzerland Startup Jobs and Abbott. As per MCA filings, the company has open charges of ₹230 Cr and satisfied charges of ₹243 Cr on record. Court records list 539 cases involving the company, including 397 filed by the company and 144 filed against it; 199 cases are pending. The company has 8 deals on record (3 funding rounds, 3 convertible or debt financings, 2 rights issues), with disclosed funding of ₹20,415 Cr; the latest was in March 2019. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations) are compared by revenue, 2 larger and 2 smaller; the largest is Torrent Pharmaceuticals Ltd with revenue of ₹11,539 Cr. The company has 23 MSME Form 1 returns on record between 2019 and 2024, listing 8,146 overdue payments to 697 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abbott.co.in.
Company details
Name history
Abbott Healthcare has undergone 2 name changes throughout its history. The company was previously known as Knoll International Limited, and Knoll International Private Limited. The current legal name is Abbott Healthcare Private Limited.
| Company Name | Status |
|---|---|
| Abbott Healthcare Private Limited | Current |
| Knoll International Limited | Previous |
| Knoll International Private Limited | Previous |
Contact details
Abbott Healthcare Private Limited's registered office is in Mumbai, Maharashtra. Its website is abbott.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit No. 3 Corporate Park Sion Trombay Road Chembur, Mumbai, Maharashtra, India – 400071
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Abbott Healthcare Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Abbott Healthcare operates multiple associated brands including Pediasure, Switzerland Startup Jobs, and Abbott. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides science-based nutritional products for supporting child growth and health worldwide. | pediasure.in | |
| Online sales of anabolic steroids and health supplements for athletes. | switzerlandstartupjobs.com | |
| Developer of medical devices, generic pharmaceuticals, and nutrition products | abbott.com |
Business activity
The main business activities of Abbott Healthcare are manufacturing and trade. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations, food, beverages and tobacco products and wholesale trading. 3 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | |
| C | Manufacturing | C1 | Food, beverages and tobacco products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Abbott Healthcare Private Limited, buy the company report.
Financials of Abbott Healthcare Private Limited
FY 2025 filings availableAbbott Healthcare Private Limited reported revenue of ₹8,811.32 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 3% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹8,811.32 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,792.39 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,104.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.3% | ||||
| Net Profit Margin | 12.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Abbott Healthcare Private Limited, buy the company report.
Board of directors of Abbott Healthcare Private Limited
Abbott Healthcare has 4 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Scott Michael Leinenweber | Director | 19 Aug 2015 | 11 Years 3 Months | Current |
| Ramanathan | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Kunal Chowdhury | Additional Director | 21 Feb 2025 | 1 Years 8 Months | Current |
| Anirban Basu | Additional Director | 08 Aug 2025 | 1 Years 3 Months | Current |
Peer comparison
Abbott Healthcare Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd | ₹11,539 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India | |||
| Ipca Laboratories Limited | ₹9,032.39 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Abbott Healthcare Private Limitedthis company | ₹8,811.32 Cr (FY 2025) | ₹1,104.4 Cr | 12.5% | 3.0% | 8,323 | Mumbai, Maharashtra, India |
| Emcure Pharmaceuticals Limited | ₹7,963.26 Cr (FY 2025) | 19.0% | Pune, Maharashtra, India | |||
| Jubilant Pharmova Limited | ₹7,291.3 Cr (FY 2025) | 8.0% | Uttar Pradesh, India |
To see the full peer comparison of Abbott Healthcare Private Limited, buy the company report.
Auditor
Abbott Healthcare Private Limited is audited by S R B C & CO LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2025 | 324982E/E300003 |
Shareholding
The shareholding of Abbott Healthcare Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Abbott Healthcare Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Sep 2010 | 10237333 | Standard Chartered Bank | ₹230 Cr | Satisfied | |
| 30 Aug 2010 | 10240233 | Bnp Paribas | ₹10 Cr | Satisfied | |
| 12 May 2004 | 80060894 | Bnp Paribas | ₹3 Cr | Satisfied |
To see the full charge records of Abbott Healthcare Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Abbott Healthcare Private Limited has 8 deals on record (3 funding rounds, 3 convertible or debt financings, 2 rights issues), with disclosed funding of ₹20,415 Cr; the latest was in March 2019.
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Rights issue | ₹231.89 Cr | Investors: Abbott Asia Holdings Limited |
| May 2018 | Rights issue | ₹146.17 Cr | Investors: Abbott Asia Holdings Limited |
| Dec 2012 | Funding round | ₹2,218.19 Cr | Investors: Abbott Asia Holdings Limited |
| Jan 2012 | Funding round | ₹1,835.2 Cr | Investors: Abbott Asia Holdings Limited |
| Feb 2011 | Funding round | ₹10,764 Cr | Investors: Abbott Asia Holdings Limited |
To see the full deal history of Abbott Healthcare Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Abbott Healthcare Private Limited has 539 court cases on record: 397 filed by Abbott Healthcare, 144 filed against it. 199 cases are pending and 340 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 368 | 92 | 156 |
| High courts | 149 | 35 | 39 |
| Supreme Court | 19 | 14 | 2 |
| NCLAT | 2 | 2 | 2 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 539)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Wellness Diabetacare Pvt.Ltd | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed by the company against Shree Maruti Nandan Pharmaceuticals Pvt Ltd | Pending |
| District court, North Twenty Four Parganas, West Bengal | Civil suit | Filed against the company by Agarpara Jute Mills Ltd,Jitendra Nath Choubey | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed against the company by Wellness Diabetacare Pvt.Ltd | Pending |
| Bombay High Court | Writ petition | Filed against the company by Piramal Healthcare Ltd | Disposed |
To see the full case history of Abbott Healthcare Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Abbott Healthcare Private Limited has 23 MSME Form 1 returns on record between 2019 and 2024, listing 8,146 overdue payments to 697 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 697)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Worxogo Solutions Private Limited | |||
| an individual supplier | |||
| Asian Supply Chain Solutions Private Limited | |||
| Rosefinch Marketing Private Limited | |||
| Yesh Prabha Clearing and Forwarding |
To see the full MSME payment records of Abbott Healthcare Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Abbott Healthcare Private Limited has a workforce of 8,323 employees on its EPFO records as of May 2026, across 4 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 8,323 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Abbott Healthcare Private Limited, buy the company report.
GST
Abbott Healthcare has 33 GST registrations: 25 active and 8 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACK3935D1ZS | Maharashtra | Active | 01 Jul 2017 |
| 27AAACK3935D2ZR | Maharashtra | Active | 21 Sep 2017 |
| 02AAACK3935D1Z4 | Himachal Pradesh | Active | 01 Jul 2017 |
| 03AAACK3935D1Z2 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Abbott Healthcare Private Limited, buy the company report.
Recent activity
Abbott Healthcare Private Limited has 24 board changes on record since 2009: 6 appointments and 18 cessations. The latest: Anirban Basu was appointed as Additional Director on 08 Aug 2025.
22 earlier events are in the company report.
News
Frequently asked questions
Abbott Healthcare is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 January 1997 (29+ years old) and is registered under CIN U24200MH1997PTC104834.
Abbott Healthcare has 4 current directors:
- Scott Michael Leinenweber - Director
- Ramanathan - Director
- Kunal Chowdhury - Additional Director
- Anirban Basu - Additional Director
The latest financial statements of Abbott Healthcare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Abbott Healthcare is 27AAACK3935D1ZS, registered in Maharashtra. The company has 33 GST registrations in all, of which 25 are active and 8 are cancelled or inactive. Other active GSTINs include 27AAACK3935D2ZR (Maharashtra), 02AAACK3935D1Z4 (Himachal Pradesh), 03AAACK3935D1Z2 (Punjab).
The CIN (Corporate Identification Number) of Abbott Healthcare is U24200MH1997PTC104834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abbott Healthcare has 539 court cases on record: 397 filed by the company and 144 filed against it. 199 are pending. Most are in the district courts.
Abbott Healthcare was incorporated on 01 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
Abbott Healthcare has 8 deals on record (3 funding rounds, 3 convertible or debt financings, 2 rights issues), with disclosed funding of ₹20,415 Cr; the latest was in March 2019.
The peers of Abbott Healthcare by revenue are Torrent Pharmaceuticals Ltd, Ipca Laboratories Limited, Emcure Pharmaceuticals Limited, Jubilant Pharmova Limited, all in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Anirban Basu was appointed as Additional Director on 08 Aug 2025. Kunal Chowdhury was appointed as Additional Director on 21 Feb 2025. Burjor Kersasp Dadachanji ceased to be Additional Director on 29 Sep 2024. Abbott Healthcare has 24 board changes on record in total.
Abbott Healthcare has 23 MSME Form 1 returns on record between 2019 and 2024, listing 8,146 overdue payments to 697 micro and small suppliers. The latest return was filed on 25 Apr 2024.
Abbott Healthcare can be reached through the website abbott.co.in. Its registered office is in Mumbai, Maharashtra, India.

